Current Listing of Continuing Education Courses for Nurses


Laura LaRue DNP, FNP-BC


Upon completion of this CE learning module, participants will be able to:

  • Review the use in clinical practice of antiplatelets, anticoagulants and non-vitamin k anticoagulants.
  • Review the effect of Vitamin K on clotting factors in the liver.
  • Assess data from key anticoagulation stroke prevention trials, including efficacy and safety of novel oral anticoagulants (NOACs).
  • Review the pharmacology of antiplatelets, anticoagulants to include NOACs and their clinical relevance in evidence-based guidelines.
  • Review possible ways to reverse bleeding of non-vitamin K oral anticoagulants (NOACs).
  • Evaluate reasons for underuse of oral anticoagulants for stroke prevention in patients at thromboembolic risk.
  • Apply proper anticoagulation dosing to ensure greater efficacy and safety for stroke prevention in patients at thromboembolic risk.
  • Discuss strategies to manage bleeding events. 
  • Discuss use of these anticoagulant agents in patients with renal impairment.    


Thrombus causes most of cardiovascular diseases and deaths. Thrombus is the most common cause of three cardiovascular disorders to including ischemic heart disease (acute coronary syndrome), stroke and venous thromboembolism (VTE) (ISTH Steering Committee, 2014).

Thromboembolism deaths in the United States are estimated at 300,000 annually. According to the CDC in 2013, there was between 60,000 to 100,000 deaths from venous thrombus (CDC, 2015).  The incidence nearly doubles in each decade of life over the age of 50. Individuals considered at high risk for blood clots include: trauma patients, surgical patients especially total knee replacement (TKR) and total hip replacement (THR), stroke patients, MI patients, spinal cord injury patients and metastatic cancer patients.

This continuing education will focus on common indicators for use of anticoagulants, antiplatelets and novel oral anticoagulants (NOACs). Another goal of this educational unit is to understand how clots are formed and how to treat clots appropriately.



Marjorie Young, DNP, RN, IBCLC, FNP-BC


At the completion of this continuing education module, the participant will be able to:

1.            Discuss the pathophysiology of vaginitis.

2.            Discuss the negative impact of vaginitis on health and quality of life.

3.            Identify risk factors for developing vaginitis.

4.            Describe the diagnostic techniques for vaginitis.

5.            Identify and differentiate the most common types of vaginitis.

6.            Describe the diagnostic strategies to differentiate between the different types of vaginitis.

7.            Discuss current medication, complementary, and alternative therapies for vaginitis.


Vaginal symptoms are one of the leading reasons that women seek medical care via their primary care provider, gynecologist, urgent care center, or emergency department. Self-diagnosis and treatment lead to inappropriate and under treatment of vaginal infections. The four most common causes of vaginitis consists of atopic vaginitis, bacterial vaginosis, candida vulvovaginitis, and trichomoniasis. The purpose of this module is to provide nurse practitioners with the current information on vaginitis consisting of the pathophysiology, symptomology, risk factors, negative health impacts, and diagnostic techniques along with strategies for treatment including medication, complementary and alternative therapies.